Skip to content

Clinical trials

Mucopolysaccharidosis II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20071
20084
20095
20102
20112
20123
20131
20147
20154
20161
20177
20187
20193
20204
20214
20229
20235
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting15
Terminated9
Recruiting4
Enrolling by invitation3
Withdrawn3
Unknown status2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire15
JCR Pharmaceuticals Co., Ltd.7
REGENXBIO Inc.6
Green Cross Corporation5
Takeda5
Denali Therapeutics Inc.4
AO GENERIUM3
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center3
Duke University2
GC Biopharma Corp2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II77
Sudden Infant Death33
Mucopolysaccharidosis I20
Lysosomal Storage Diseases15
Mucopolysaccharidoses15
Mucopolysaccharidosis VI15
Leukodystrophy, Metachromatic9
Leukodystrophy, Globoid Cell8
Mucopolysaccharidosis III8
Mucopolysaccharidosis VII8

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.